Bio Philadelphia sets new record for partnering meetings in an edition with 37 Catalan companies and organizations

A total of 29 companies and 8 institutions from Catalonia participated in BIO Convention 2015, the most important biotechnology convention in the world held this year in Philadelphia (United States) from 15 to 18 June. This year’s Convention hosted 29,279 partnering meetings, a new record for the event. The event drew 15,858 industry leaders from 69 countries

The Catalan delegation, coordinated by Biocat, had a booth at BIO 2015, in the Spanish pavilion. Seven Catalan companies and organizations had their own booth: Bcn Peptides, Bioibérica, Laboratorios Salvat, Barcelona Science Park, Som Biotech, Specific Pig and Trifermed.

The Catalan delegation wase made up of a total of 29 companies, including biotechnology firms AB-Biotics, Ability Pharmaceuticals, Bcn Peptides, Bioingenium, Biokit, Bionure, GP Pharm, Intelligent Pharma, Molomics, Oryzon Genomics, Plasma Biotech, Proteodesign,Som Biotech, Specific Pig, Spherium Biomed and Thrombotargets; pharmaceutical companies Almirall, Bioibérica, Esteve, Ferrer Internacional, Gebro Pharma, Grifols Internacional, Laboratorios Salvat, Lacer and Mitelos Bioscience; and service and consultancy companies Grifols Engineering, Insights in Life Sciences, Oficina Ponti and Trifermed.

There was also 8 institutions: ACCIÓ, the Government of Catalonia business competitiveness agency; Barcelona Clinical Trials Platform (BCTP), an initiative promoted by the Catalan Ministry of Health and Biocat to position Catalonia among the top five European regions to conduct clinical trials; the Polytechnic University of Catalonia (UPC) Biomedical Engineering Research Center; Center for Genomic Regulation (CRG); Institute for Research in Biomedicine of Barcelona (IRB); Barcelona Science Park (PCB); Vall d’Hebron Research Institute (VHIR) and Biocat, which was coordinating the Catalan delegation to BIO for the ninth consecutive year.